ASP Isotopes Inc. Common Stock cash flow to debt ratio of -17.49% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

ASP Isotopes Inc. Common Stock's free cash flow has decreased 69.00% from $-28.07M last year to $-47.43M, signaling decreasing performance

ASP Isotopes Inc. Common Stock's debt to equity ratio is 0.91, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy

ASP Isotopes Inc. Common Stock's debt has increased relative to shareholder equity from 0.79 last year to 0.91 today, signaling weakened financials

ASP Isotopes Inc. Common Stock has negative EBITDA, making leverage ratio unreliable

ASP Isotopes Inc. Common Stock earns at least as much interest as it pays. Interest obligations are fully covered.

ASP Isotopes Inc. Common Stock's profit margin has increased (-17.41%) in the last year from -780.26% to -644.41%, signaling increasing performance

ASP Isotopes Inc. Common Stock's short-term assets of $398.14M exceed its short-term liabilities of $32.70M

ASP Isotopes Inc. Common Stock's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

ASP Isotopes Inc. Common Stock's return on equity of -117.16%, is lower than 15.00%, indicating bad performance

ASP Isotopes Inc. Common Stock's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

ASP Isotopes Inc. Common Stock had positive net income in only 0.00 out of 5 years, indicating unstable earnings

ASP Isotopes Inc. Common Stock has negative free cash flow, indicating the company is burning cash rather than generating it

ASP Isotopes Inc. Common Stock has negative free cash flow, indicating cash burn

ASP Isotopes Inc. Common Stock's yearly earnings has decreased 441.51% since last year from $-32.33M to $-175.09M, signaling decreasing performance

ASP Isotopes Inc. Common Stock's yearly revenue has increased 475.48% since last year from $4.14M to $23.85M, signaling increasing performance

ROIC -12.97% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

ASP Isotopes Inc. Common Stock has insufficient revenue history to calculate 3-year revenue CAGR.

ASP Isotopes Inc. Common Stock had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance

ASP Isotopes Inc. Common Stock had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity

ASP Isotopes Inc. Common Stock has insufficient data to evaluate this check.

ASP Isotopes Inc. Common Stock has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

ASP Isotopes Inc. Common Stock is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

ASP Isotopes Inc. Common Stock has negative or missing EBITDA, making EV/EBITDA ratio unreliable

ASP Isotopes Inc. Common Stock has insufficient data to evaluate this check.

ASP Isotopes Inc. Common Stock has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

ASP Isotopes Inc. Common Stock has a price-to-book ratio of 2.58x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

ASP Isotopes Inc. Common Stock has a price-to-sales ratio of 19.04x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue